{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:12:27Z","timestamp":1792818747483,"version":"4.5.0"},"reference-count":110,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Oncol"],"abstract":"<jats:p>Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of over 95%. However, the undifferentiated or anaplastic type accounting for &lt; 0.2%, usually in elderly individuals, exhibits a dismal prognosis with rapid growth and disappointing outcomes. It is the most aggressive form of thyroid carcinoma, with a median survival of 5 mo and poor quality of life (airway obstruction, dysphagia, hoarseness, persistent pain). Early diagnosis and staging are crucial. Diagnostic tools include biopsy (fine needle aspiration, core needle, open surgery), high-resolution ultrasound, computed tomography, magnetic resonance imaging, [(18)F]fluoro-D-glucose positron emission tomo-graphy\/computed tomography, liquid biopsy and microRNAs. The BRAF  gene (BRAF-V600E  and BRAF  wild type) is the most often found molecular factor. Others include the genes RET, KRAS, HRAS,  and NRAS . Recent management policy is based on surgery, even debulking, chemotherapy (cisplatin or doxorubicin), radiotherapy (adjuvant or definitive), targeted biological agents and immunotherapy. The last two options constitute novel hopeful management modalities improving the overall survival in these otherwise condemned patients. Anti-programmed death-ligand 1 antibody immunotherapy, stem cell targeted therapies, nanotechnology achievements and artificial intelligence imple-mentation provide novel promising alternatives. Genetic mutations determine molecular pathways, thus indicating novel treatment strategies such as anti-BRAF, anti-vascular endothelial growth factor-A, and anti-epidermal growth factor receptor. Treatment with the combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib has been approved by the Food and Drug Administration in cases with BRAF-V600E  gene mutations and is currently the standard care. This neoadjuvant treatment followed by surgery ensures a two-year overall survival of 80%. Prognostic factors for improved outcomes have been found to be younger age, earlier tumor stage and radiation therapy. A multidisciplinary approach is necessary, and the therapeutic plan should be individualized based on surveillance and epidemiology end results.<\/jats:p>","DOI":"10.5306\/wjco.v14.i12.570","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T04:02:31Z","timestamp":1703131351000},"page":"570-583","source":"Crossref","is-referenced-by-count":32,"title":["Update on current diagnosis and management of anaplastic thyroid carcinoma"],"prefix":"10.5306","volume":"14","author":[{"given":"Efstathios T","family":"Pavlidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis N","family":"Galanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros E","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2023,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0415"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.05.009"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.wjorl.2018.05.006"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09833-1"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0080"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041061"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v14.i7.247"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-277"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8428547"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01368-5"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.2018_85-3"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06041-2"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-023-10208-8"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/65155"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169653"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy123"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000740"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X221091399"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-03249-8"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.854755"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-3921-y"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2022.09.005"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2022.03.010"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.10.18"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.22038\/IJBMS.2023.69174.15069"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147707"},{"key":"B27","doi-asserted-by":"crossref","unstructured":"Khatami F, Tavangar SM. Liquid Biopsy in Thyroid Cancer: New Insight. Int J Hematol Oncol Stem Cell Res 2018; 12: 235-248","DOI":"10.2147\/PGPM.S181520"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.3c01984"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2174\/1568009623666230707155145"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1039\/d3ra02121a"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/life13061397"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02751-9"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2023.05.006"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22669"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0339"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04223-7"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05302-z"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.29150.sha"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz400"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1103147"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000823"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2022.5045"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000619"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13945-y"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.971249"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2017.1383536"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/lary.30724"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00776-2"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2021.06.009"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22519"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0344"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10194"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2021.04.005"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2244228"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0278"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.1379"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107272"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15458"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1471_22"},{"key":"B60","unstructured":"Manjusha P, Kandathil JP, Nayanar SK, Jones J, Sajith B. Clinicopathological Spectrum of Anaplastic Carcinoma of Thyroid - 5 Year Experience from a Tertiary Cancer Centre. Gulf J Oncolog 2018; 1: 17-22"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030552"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231169870"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-1364"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-503"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10146-3"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011037"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5545127"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0040"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0089"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1727"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0903-0"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.748023"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00763-X"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03390-y"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0036"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-023-02249-w"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188928"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-021-00822-7"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082164"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0509"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_404770"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02321-8"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-023-00147-7"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0597"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.14002"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2223383"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-22-1031"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02282-2"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097872"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0378-y"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0201"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104744"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.10.010"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02727"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0073"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1187388"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2976"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02063-0"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225258"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1055\/a-0859-7454"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13910"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31252"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.3362"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/lary.30277"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14915"},{"key":"B107","unstructured":"Hussain SA, Subbiah S, Bharathiraja MS. Anaplastic Carcinoma Thyroid - A Review on the Management of this Aggressive Cancer. Gulf J Oncolog 2018; 1: 37-41"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30162-5"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.830760"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03085-w"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v14\/i12\/570.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v14\/i12\/570.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T04:16:53Z","timestamp":1703132213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v14\/i12\/570.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,24]]},"references-count":110,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.5306\/wjco.v14.i12.570","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,24]]}}}